Meet Yin Li: China’s New SFDA Chief Has A Public Health Background, And International Ties
This article was originally published in PharmAsia News
Vice Minister of Health Yin Li assumes post as director of China’s State FDA, taking reigns from Shao Mingli, who led the agency since 2005.
You may also be interested in...
China's Center For Drug Evaluation Remakes Itself To Enter New Era Of Transparency, Speed Up Approvals
SHANGHAI - For years, China has talked about revising its drug review system to improve efficiency, and now major changes are in the works with China's State FDA reforming its drug review body, the Center for Drug Evaluation, to encourage drug innovation and facilitate globalization of its drug review process
BEIJING - As China's government mulls whether to galvanize a dozen vaccine producers across the country to turn out up to 300 million doses of an A/H1N1 defense and continues with the rapid-fire quarantine of anyone suspected of having contact with swine flu victims, health authorities are meeting with World Health Organization representatives to coordinate closely Beijing's response to the pandemic
China executed Zheng Xiaouy, the former head of the State Food and Drug Administration, July 10 for dereliction of duty and for accepting $850,000 worth of bribes from pharmaceutical companies, according to the official Xinhua news service